Puma Biotechnology, Inc. (PBYI)
9.78
-0.04
(-0.41%)
USD |
NASDAQ |
Sep 29, 16:00
9.78
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Market Cap : 499.78M for Sept. 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 28, 2026 | 501.83M |
| September 25, 2026 | 499.27M |
| September 24, 2026 | 501.83M |
| September 23, 2026 | 474.23M |
| September 22, 2026 | 501.83M |
| September 21, 2026 | 490.07M |
| September 18, 2026 | 490.59M |
| September 17, 2026 | 486.50M |
| September 16, 2026 | 479.85M |
| September 15, 2026 | 472.70M |
| September 14, 2026 | 467.08M |
| September 11, 2026 | 466.06M |
| September 10, 2026 | 468.61M |
| September 09, 2026 | 462.48M |
| September 08, 2026 | 479.85M |
| September 04, 2026 | 488.03M |
| September 03, 2026 | 480.88M |
| September 02, 2026 | 495.19M |
| September 01, 2026 | 477.81M |
| August 31, 2026 | 465.55M |
| August 28, 2026 | 462.99M |
| August 27, 2026 | 472.19M |
| August 26, 2026 | 468.10M |
| August 25, 2026 | 476.28M |
| August 24, 2026 | 466.06M |
| Date | Value |
|---|---|
| August 21, 2026 | 472.19M |
| August 20, 2026 | 465.55M |
| August 19, 2026 | 484.96M |
| August 18, 2026 | 472.19M |
| August 17, 2026 | 450.73M |
| August 14, 2026 | 451.24M |
| August 13, 2026 | 445.10M |
| August 12, 2026 | 454.81M |
| August 11, 2026 | 448.17M |
| August 10, 2026 | 444.08M |
| August 07, 2026 | 455.33M |
| August 06, 2026 | 414.95M |
| August 05, 2026 | 408.31M |
| August 04, 2026 | 398.60M |
| August 03, 2026 | 391.26M |
| July 31, 2026 | 403.47M |
| July 30, 2026 | 401.44M |
| July 29, 2026 | 397.37M |
| July 28, 2026 | 405.51M |
| July 27, 2026 | 406.52M |
| July 24, 2026 | 406.02M |
| July 23, 2026 | 407.54M |
| July 22, 2026 | 400.42M |
| July 21, 2026 | 436.54M |
| July 20, 2026 | 422.30M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 267.12M |
| Arcutis Biotherapeutics, Inc. | 3.360B |
| ACADIA Pharmaceuticals, Inc. | 3.480B |
| Alnylam Pharmaceuticals, Inc. | 34.00B |
| Savara, Inc. | 1.045B |
Market Cap Related Metrics
| PE Ratio | 18.94 |
| PS Ratio | 2.177 |
| Price to Book Value | 3.607 |
| Price to Free Cash Flow | 12.23 |
| Price | 9.78 |
| Earnings Yield | 5.28% |
| Operating PE Ratio | 16.54 |
| Normalized PE Ratio | 18.94 |